Ulipristal Acetate for Treatment of Uterine Leiomyomas-Reference-Cited by-同舟云学术

Ulipristal Acetate for Treatment of Uterine Leiomyomas

Published:2018-11 Issue:5 Volume:132 Page:1241-1251
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Liu James H.,Soper David,Lukes Andrea,Gee Phyllis,Kimble Thomas,Kroll Robin,Mallick Madhuja,Chan Anna,Gillard Patrick,Harrington Amanda,Sniukiene Vilma,Shulman Lee P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference23 articles.

1. Uterine fibroids;Stewart;Nat Rev Dis Primers,2016

2. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence;Baird;Am J Obstet Gynecol,2003

3. Uterine leiomyomas: individualizing the approach to a heterogeneous condition;Laughlin;Obstet Gynecol,2011

4. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race;Marshall;Obstet Gynecol,1997

5. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women;Zimmermann;BMC Womens Health,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update;Journal of the American College of Radiology;2024-06

2. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial;F&S Science;2023-11

3. Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study;Efficacy and Mechanism Evaluation;2023-10

4. Contemporary approaches in the management of uterine leiomyomas;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08

5. Targeting nuclear hormone receptors for the prevention of breast cancer;Frontiers in Medicine;2023-07-31